Fair Value Calculator Fair Value Calculator
EN DE

VASUPRADA (VASUPRADA) Fair Value & Analysis

IN · Market cap ₹837M

V VASUPRADA VASUPRADA · BSE
Price₹97.00
Fair Value₹23.53
Upside-75.7%
Quality48/100
Watch VASUPRADA for free — get notified when fair value or trend changes. Watch for free
Evidence: Medium Range ₹4.71 – ₹52.91

Fair value as of: Jul 6, 2026

From 10 valuation models · updated today

Share price −7.6% over the past month.

Price vs Fair Value (12 months)

₹127.95 ₹90.00 Fair Value ₹23.53 May 2025 Jul 2026

12‑month range ₹90.00 – ₹127.95 · fair‑value band ₹4.71 – ₹52.91 · the ₹97.00 price screens above the ₹23.53 fair value. As of Jul 6, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

VASUPRADA (VASUPRADA) currently trades at ₹97.00, while our model-based Fair Value estimate is ₹23.53 — implying the stock looks roughly 75.7% overvalued today. We read business quality at 48/100 (below-average quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

Over the trailing twelve months, VASUPRADA generated revenue of ₹1.4B at a net margin of -5.0%. Revenue declined 30.5% year over year. It earns a return on equity of -5.8%. Net debt stands at ₹595M. Fundamentals as of Jul 6, 2026

Our scenario range runs from ₹4.71 (bear case) to ₹52.91 (bull case); at ₹97.00, the current price sits above that range. The share trades about 27% below its 52-week high and 13% above its 52-week low, currently below its 200-day average.

Key figures & financial health

Revenue (TTM) ₹1.4B
Revenue growth (YoY) -30.5%
Net margin -5.0%
Return on equity -5.8%
Free cash flow ₹30.8M FY2026
Operating margin -2.3%
More key figures
EPS (TTM) ₹-8.59
EPS growth (YoY) -43.3%
Net debt ₹595M FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 6, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

VASUPRADA reported revenue of ₹1.4B in FY2026 versus ₹1.2B in FY2022, a compound +4.5%/yr. Reported net income was −₹71.2M in FY2026.

Revenue +4.5%/yr
FY22 ₹1.2B
FY23 ₹1.1B
FY24 ₹1.1B
FY25 ₹1.3B
FY26 ₹1.4B
Net income
FY22 −₹148M
FY23 −₹108M
FY24 −₹66.3M
FY25 ₹61.0M
FY26 −₹71.2M

Is VASUPRADA fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "VASUPRADA Fair Value". https://www.fairvalue-calculator.com/stock/VASUPRADA

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is VASUPRADA (VASUPRADA) undervalued?
As of Jul 6, 2026, our model estimates a fair value of ₹23.53 versus a price of ₹97.00 — about −76% (overvalued). Model-based estimate, not financial advice.
What is the fair value of VASUPRADA?
Our model-based fair value for VASUPRADA is ₹23.53 (as of Jul 6, 2026), built from audited fundamentals. The current price is ₹97.00.
What is the quality score of VASUPRADA?
VASUPRADA has a Quality Score of 48/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of VASUPRADA (VASUPRADA)?
VASUPRADA reported trailing-twelve-month revenue of about ₹1.4B (latest available figure, as of Jul 6, 2026).
What is the net profit margin of VASUPRADA?
The net profit margin of VASUPRADA is about -5.0%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.